About China Growth Development, Inc. (OTC: CGDI)
China Growth Development Inc. provides high quality leasing opportunities for both retail and wholesale clients in convenient, modern shopping centers. China Growth Development Inc. is the largest investor, owner and manager of commercial real estate in the capital city of Taiyuan, located in the Shanxi province of southern China. China Growth Development Inc., owns and manages , commercial units within its six strategically located shopping centers, servicing and urban population of . million people.
- Phone: 6265819069
- Aizhong An / CEO
- Samuel Liu / President, COO, Secretary
- Jiming Zhu / Vice President, CFO, Treasurer
- Junhui An / Vice President
- Aizhong An / Chairman
- Junhui An /
- Omar A. Gonzalez /
- Samuel Liu /
- Jiming Zhu /
Current Share Structure
- Market Cap: $175,549 - 05/11/2018
- Issue and Outstanding: 34,970,007 - 08/20/2008
Daily Technical Chart for (OTC: CGDI)
Stay tuned for daily updates and more on (OTC: CGDI)
More to come on (OTC: CGDI)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CGDI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CGDI and does not buy, sell, or trade any shares of CGDI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/